We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 17 MAY 2016
BRPTO Stands Up To ANVISA For Pharmaceuticals
Clarke, Modet & Co
As you already know, for the allowance of pharmaceutical patents, the Brazilian IP Law currently requires the prior consent from ANVISA (Brazilian Health Surveillance Agency – equivalent to American FDA) along with the usual examination from the BRPTO.
BrazilIntellectual Property


